P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000973580.07128.32 |
| _version_ | 1797281646998716416 |
|---|---|
| author | Pramila Krishnamurthy Myrsini Gianatsi Sophie Wintrich Abin Thomas Lynn Quek Austin Kulasekararaj Priyanka Mehta Sreetharan Munisamy Nigel Russell Mike Dennis Elspeth Payne Ian Thomas |
| author_facet | Pramila Krishnamurthy Myrsini Gianatsi Sophie Wintrich Abin Thomas Lynn Quek Austin Kulasekararaj Priyanka Mehta Sreetharan Munisamy Nigel Russell Mike Dennis Elspeth Payne Ian Thomas |
| author_sort | Pramila Krishnamurthy |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:00:26Z |
| format | Article |
| id | doaj.art-d97effce40d44db99dd4f45c4c4e1ef9 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:00:26Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-d97effce40d44db99dd4f45c4c4e1ef92024-03-03T03:24:55ZengWileyHemaSphere2572-92412023-08-017e071283210.1097/01.HS9.0000973580.07128.32202308003-01569P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALSPramila Krishnamurthy0Myrsini Gianatsi1Sophie Wintrich2Abin Thomas3Lynn Quek4Austin Kulasekararaj5Priyanka Mehta6Sreetharan Munisamy7Nigel Russell8Mike Dennis9Elspeth Payne10Ian Thomas111 King’s College Hospital, United Kingdom2 Cardiff University, United Kingdom3 MDS UK Patient Support Group, United Kingdom2 Cardiff University, United Kingdom4 King’s College London, United Kingdom1 King’s College Hospital, United Kingdom5 University Hospital Bristol, United Kingdom6 Kent and Canterbury Hospital, United Kingdom7 Guy’s Hospital, United Kingdom8 Christie Hospital Nhs Trust, United Kingdom9 University College London, United Kingdom2 Cardiff University, United Kingdomhttp://journals.lww.com/10.1097/01.HS9.0000973580.07128.32 |
| spellingShingle | Pramila Krishnamurthy Myrsini Gianatsi Sophie Wintrich Abin Thomas Lynn Quek Austin Kulasekararaj Priyanka Mehta Sreetharan Munisamy Nigel Russell Mike Dennis Elspeth Payne Ian Thomas P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS HemaSphere |
| title | P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title_full | P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title_fullStr | P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title_full_unstemmed | P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title_short | P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title_sort | p1677 defining key quality of life metrics in acute myeloid leukaemia and high risk myelodysplastic syndrome patients enrolled in large scale uk ncri aml trials |
| url | http://journals.lww.com/10.1097/01.HS9.0000973580.07128.32 |
| work_keys_str_mv | AT pramilakrishnamurthy p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT myrsinigianatsi p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT sophiewintrich p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT abinthomas p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT lynnquek p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT austinkulasekararaj p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT priyankamehta p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT sreetharanmunisamy p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT nigelrussell p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT mikedennis p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT elspethpayne p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT ianthomas p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials |